What is mefenamic, and what is it used for?
Mefenamic is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. It is commonly prescribed for short-term relief of mild to moderate pain and for painful menstrual cramps (dysmenorrhea).
How does mefenamic work?
Like other NSAIDs, mefenamic works by reducing prostaglandins—chemicals involved in pain, fever, and inflammation. Lower prostaglandin levels lead to decreased pain and menstrual cramping.
What are common side effects people report?
Common side effects of mefenamic (typical for NSAIDs) can include stomach upset, nausea, heartburn, and abdominal pain. NSAIDs can also increase the risk of gastrointestinal irritation and bleeding.
Who should avoid mefenamic or use it only with medical advice?
Mefenamic may be unsafe for some people, especially those with:
- A history of stomach ulcers or gastrointestinal bleeding
- Significant kidney disease
- NSAID allergy or NSAID-triggered asthma reactions
- Certain cardiovascular risk situations (because some NSAIDs can raise risk)
Pregnancy timing also matters with NSAIDs; clinicians generally restrict NSAID use later in pregnancy.
How long is mefenamic usually taken?
For many uses, mefenamic is intended for short-term treatment of pain (including menstrual cramps). The exact duration depends on the condition and the prescribed dosing schedule.
Is mefenamic available generically, and is there a patent issue?
Information on mefenamic’s market exclusivity and any active patent or litigation details would depend on the specific product and jurisdiction. For up-to-date patent and exclusivity tracking, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
What questions should patients ask their clinician or pharmacist?
Patients often want clarity on:
- The correct dose and maximum daily amount
- Whether it should be taken with food to reduce stomach irritation
- What to do if pain persists after the recommended course
- Whether they should avoid combining it with other NSAIDs or certain medications
---
Sources
- https://www.drugpatentwatch.com/